HealthCare Global Enterprises Limited (“HCG”) today announced its financial results for the quarter (“Q3 FY18”) and nine months (“9M FY18”) ended December 31, 2017.
Highlights for quarter ended December 31st, 2017
- Consolidated Income from Operations (“Revenue”) was INR 2,063 mn as compared to INR 1,762 mn in the corresponding quarter of the previous year, reflecting a year-on-year increase of 17%.
- Consolidated Profit Before Depreciation and Amortization, Finance Costs, Exceptional Items and Taxes (“EBITDA”) was INR 319 mn as compared to INR 277 mn in the corresponding quarter of the previous year, reflecting a year-on-year increase of 15.3%.
- Operating EBITDA without loss from new centers was INR 309 mn as compared to INR 274 mn in the corresponding quarter of the previous year.
- ConsolidatedProfitBeforeOtherIncome,DepreciationandAmortization,FinanceCosts,ExceptionalItems and Taxes (“Operating EBITDA”) was INR 261 mn as compared to INR 260 mn in the corresponding quarter of the previous year, reflecting a year-on-year increase of 0.3%.
- Consolidated Profit after Taxes and Minority Interest (“PAT”)(4) was INR 32 million as compared to INR 54 mn in the corresponding quarter of the previous year.
Business Updates for Q3 FY18
Growing strategic focus and scale across Maharashtra.
- Nashik expansion and launch of Nagpur and Borivali led to the region contributing 9% of HCG Centers income in Q3 FY18 as compared to 4% in the corresponding quarter of the previous year; this is to further strengthen with upcoming launch of South Mumbai in Q1-FY19
- Borivali center operationalized with commencement of comprehensive radiation, surgical and medical oncology services, all under one roof, in a large and high-realization market.
